. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "2-diphenylmethoxy-N,N-demthylethanamine"@en . . . . . . . . . . . . . . "\u03B2-dimethylaminoethyl benzhydryl ether"@en . . . . . . . . . . . . . . . . . . . . . . . "Difenhidramina"@en . . . . . . . . . . . "2-(Benzhydryloxy)-N,N-dimethylethylamine"@en . . "Take with food."@en . . . . . . . . . . . . . . "beta-Dimethylaminoethanol diphenylmethyl ether"@en . . "Diphenhydramine competes with free histamine for binding at HA-receptor sites. This antagonizes the effects of histamine on HA-receptors, leading to a reduction of the negative symptoms brought on by histamine HA-receptor binding."@en . . . . . . . . " "@en . . "alpha-(2-Dimethylaminoethoxy)diphenylmethane"@en . . . . . . "98 to 99%"@en . . . . . . . . . . . . . . . "For the treatment of symptoms associated with Vertigo/Meniere's disease, nausea and vomiting, motion sickness and insect bite."@en . . . . "Avoid alcohol."@en . . . "58-73-1"@en . . . . . "N-(2-(Diphenylmethoxy)ethyl)-N,N-dimethylamine"@en . "Little, if any, is excreted unchanged in the urine; most appears as the degradation products of metabolic transformation in the liver, which are almost completely excreted within 24 hours."@en . . . "# Raphael GD, Angello JT, Wu MM, Druce HM: Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2006 Apr;96(4):606-14. \"Pubmed\":http://www.ncbi.nlm.nih.gov/pubmed/16680933"@en . . . . . . . . . "approved"@en . "1-4 hours"@en . . . . . . . . . . "Humans and other mammals"@en . "A histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects."@en . . "Diphenhydramine"@en . . . . "beta-Dimethylaminoethyl benzhydryl ether"@en . " "@en . . . . . . . . . . . . . . . . "LD₅₀=500 mg/kg (orally in rats). Considerable overdosage can lead to myocardial infarction (heart attack), serious ventricular dysrhythmias, coma and death."@en . . . . . . . . . . . . . "Quickly absorbed with maximum activity occurring in approximately one hour."@en . . . . . . . . "Alison B. Lukacsko, Joseph J. Piala, \"Effect of a combination of a terbutaline, diphenhydramine and ranitidine composition on gastrointestinal injury produced by nonsteroidal anti-inflammatory compositions.\" U.S. Patent US5260333, issued December, 1983."@en . "O-benzhydryldimethylaminoethanol"@en . . . . . . . . . . . . . . . . . . . . . . . . . "Diphenhydraminum"@en . . . . . . . . . . . . . . . . . . . . . . . .